Metrika SGR, an Italian private equity firm focused on healthcare investments, has acquired a majority stake in Agliati, a leading manufacturer of dental implants and prosthetics based in Italy. The acquisition aims to establish the first industrial hub for dental implantology and prosthetics in the country.

Deal At A Glance
Acquirer:Metrika SGR (Italy)
Target:Agliati S.r.l. (Italy)
Value:Undisclosed
Type:Acquisition
Closing Date:2023-07-03

The transaction was financed through medium-term loans provided by Anthilia BIT III and Anthilia BIT IV funds. Agliati’s founding family will retain a minority stake in the company to ensure operational continuity.

Strategic Rationale

Metrika SGR's investment in Agliati is driven by its vision to consolidate the Italian dental implantology market and foster innovation within the sector. The acquisition of Agliati, which has been a pioneer in the development and production of high-quality dental prosthetics since 1987, will enhance Metrika’s portfolio with cutting-edge technologies and a strong brand reputation.

By combining forces, both companies aim to establish an industrial hub that can drive further advancements in dental implantology research and development. This strategic move positions the combined entity as a leader in the fast-growing European market for dental implants and prosthetics.

Financial Context

The financial terms of the deal were not disclosed, but it is understood that Anthilia’s funds will provide medium-term financing to support Agliati's continued growth and development. This approach aligns with Metrika SGR's investment strategy of providing long-term capital for businesses with strong market positions.